Xiaomei Lyu | Genetic Engineering and Biotechnology | Best Researcher Award

Published on by New Scientists

Prof. Xiaomei Lyu | Genetic Engineering and Biotechnology | Best Researcher Award

Professor | Jiangnan University | China

Prof. Xiaomei Lyu is a leading researcher in synthetic biology-driven food science, microbial engineering, and biotechnology. Her work focuses on designing programmable microbial systems, metabolic pathway engineering, and CRISPR-based genetic regulation for applications in food functionality, metabolic health, and biomanufacturing. Her research contributions span high-impact areas such as microbial biosensing, host–microbe interaction engineering, and sustainable biosynthesis of value-added compounds. Prof. Xiaomei Lyu has contributed significantly to the development of engineered microbial genetic circuits targeting biomedical and functional-food applications. Her notable advancements include CRISPR-regulated biosensing systems and controllable nanocarriers enabling active delivery of gene-editing components (Small, 2021). She has also pioneered strategies for modularizing and optimizing metabolic pathways in microbial chassis to enhance production efficiency of nutraceutical compounds, as demonstrated in her work on delta-tocotrienol biosynthesis (Journal of Agricultural and Food Chemistry, 2023). Her research on Rhizobium-derived beta-glucan has opened new avenues in microbiota-modulated metabolic regulation. These works revealed mechanisms by which microbial polysaccharides influence triglyceride metabolism, intestinal fat absorption, and gut–host crosstalk, producing valuable implications for obesity and metabolic disorder interventions (Food & Function, 2022; 2024). Additionally, Prof. Xiaomei Lyu has made recognized contributions to enzymatic and chemo-catalytic processes relevant to food biotechnology, including lactulose production and salidroside biosynthesis, helping advance industrial and functional food innovation. Her publication record includes influential papers in Nature Communications, Small, Food & Function, Biotechnology Advances, Phytochemical Reviews, and Journal of Agricultural and Food Chemistry, supported by strong citation performance (Scopus: 1,515 citations, 59 documents, h-index 22). Her scholarly impact extends to R&D in microbial engineering, biochemical pathways, food-derived therapeutics, and microbiome-based metabolic interventions. Prof. Xiaomei Lyu’s research achievements establish her as a prominent contributor to next-generation microbial biotechnology, functional food science, and precision metabolic modulation.

Profiles: Scopus | ResearchGate | Sci Profiles

Featured Publications

1. Gu, B., Zhang, W.-D., Feng, J.-D., Zhao, W., Gu, Z.-G., & Lyu, X. (2025). Upcycling CO₂ into single cell protein via an integrated electrocatalytic–biosynthetic system. ACS Sustainable Chemistry & Engineering. https://doi.org/10.1021/acssuschemeng.5c06506

2. Wang, L., Zeng, Q., Gu, J., Wang, M., Yang, R., & Lyu, X. (2025). High conversion of value-added lactulose from lactose-rich dairy waste by in vivo cascade cell factory. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.5c03933

3. Zeng, Q., & Lyu, X. (2025). Identification of a novel cellobiose 2-epimerase from Acidobacteriota bacterium and its application for in-situ milk catalysis. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2025.1575725

4. Liu, H., Zeng, Q., Zhu, C., Xu, C., Yang, R., & Lyu, X. (2025). High-throughput screening and directed evolution of β-1,3-N-acetylglucosaminyltransferase for enhanced LNnT production in engineered Saccharomyces cerevisiae. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.5c01311

5. Liu, H., Liu, Y., Hu, H., Zhang, S., Lyu, X., & Yang, R. (2024). De novo production of LNnT by metabolic engineering of Saccharomyces cerevisiae as cell factory. Food Science and Human Wellness. https://doi.org/10.26599/fshw.2024.9250342

Akash Mourya | Health and Medicine Advances | Best Researcher Award

Published on by New Scientists

Mr. Akash Mourya | Health and Medicine Advances | Best Researcher Award

PhD Scholar | National Institutes of Pharmaceutical Education and Research | India

Mr. Akash Mourya is a promising young pharmacologist specializing in pharmacology and toxicology, with a strong research focus on liver pathophysiology, hepatoprotective drug discovery, and molecular mechanisms underlying hepatic and pulmonary disorders. His ongoing Ph.D. work at NIPER Mohali builds on extensive preclinical and translational research conducted at the Institute of Liver and Biliary Sciences (ILBS), New Delhi, where he has developed expertise in animal models of liver diseases, hemodynamic studies, and hepatic cell culture systems. His research contributions have advanced understanding of non-alcoholic and alcoholic fatty liver diseases, hepatopulmonary and porto-pulmonary hypertension, and liver regeneration mechanisms. He has co-authored seven peer-reviewed publications in high-impact journals, including Journal of Hepatology, JHEP Reports, American Journal of Physiology–Gastrointestinal and Liver Physiology, npj Gut and Liver, ACS Omega, and Life Sciences. His work has collectively received 31 citations, 7 Documents, with an h-index of 3, reflecting growing recognition within the biomedical research community. In addition to journal articles, Mr. Akash Mourya has contributed two book chapters published by Springer Nature (2024) and Academic Press (2025), covering topics such as oxidative stress and pharmacological interventions in liver disease, and PPARγ signaling in diabetes. His research abstracts have been presented at prestigious international conferences, including the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL). His work integrates pharmacological innovation, molecular biology, and experimental therapeutics, with emphasis on Ayurvedic formulations, CB2 receptor agonists, and novel siRNA nanoparticle delivery systems. Mr. Akash Mourya’s ongoing efforts contribute to translational R&D for liver protection and regeneration, aligning with India’s growing emphasis on integrative pharmacology and precision medicine.

Profiles: Scopus | Google Scholar | ResearchGate | PubMed 

Featured Publications

1. Baweja, S., Kumari, A., Negi, P., Tomar, A., Tripathi, D. M., Mourya, A. K., Rastogi, A., Subudhi, P. D., Thangariyal, S., Kumar, G., Kumar, J., Sood, A., Vashistha, C., Bihari, C., Maiwall, R., & Sarin, S. K. (2023). Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod. Journal of Hepatology, 79(1), 167–180.

2. Juneja, P., Rahman, S. N. R., Jakhar, D., Mourya, A. K., Tripathi, D. M., Kaur, I., Tiwari, V., & others. (2023). Recombinant VEGF-C (Cys156Ser) improves mesenteric lymphatic drainage and gut immune surveillance in experimental cirrhosis. JHEP Reports, 5(10), 100816.

3. Biswas, S., Yadav, N., Juneja, P., Mourya, A. K., Kaur, S., Tripathi, D. M., & Chauhan, V. S. (2022). Conformationally restricted dipeptide-based nanoparticles for delivery of siRNA in experimental liver cirrhosis. ACS Omega, 7(41), 36811–36824.

4. Kaur, I., Juneja, P., Tiwari, R., Vasudevan, A., Mourya, A. K., Trauner, M., Sarin, S. K., & Tripathi, D. M. (2024). Secondary bile acids in portal blood contribute to liver regeneration in a rat model of partial hepatectomy. American Journal of Physiology – Gastrointestinal and Liver Physiology, 327(4), G645–G658.

5. Tripathi, D. M., Singh, P., Mourya, A. K., & Kaur, S. (2024). Oxidative medicine and novel pharmacological treatment approaches in liver disease. In Adaptation under stressful environments through biological adjustments and interventions (pp. 311–334). Springer Nature.

 

R Sagaya Jansi | Biotechnology | Best Researcher Award

Published on by New Scientists

DR. R Sagaya Jansi | Biotechnology | Best Researcher Award

Assistant Professor, Stella Maris College, India

Dr. R Sagaya Jansi is an Assistant Professor in the PG Department of Bioinformatics at Stella Maris College, India, where she has served as Head of the Department since November 2019 and currently coordinates the IQAC. She earned her Ph.D. in Biotechnology (Plant Biology and Plant Biotechnology) and an M.Phil. in Plant Biology and Plant Biotechnology from Loyola College, Chennai, India, along with an M.Sc. in Biotechnology from Loyola College and a B.Sc. in Advanced Zoology and Biotechnology from Stella Maris College. She has also cleared CSIR-NET (Life Sciences, 2018), SET (Life Sciences, 2012) and GATE (2011). Dr. Jansi’s research focuses primarily on plant biotechnology and the integration of bioinformatics in molecular modeling, computer-aided drug design, genomics, and proteomics, with emerging work bridging computational approaches and molecular biology to address challenges in biomedical and plant sciences. She has extensive teaching and research experience, having served as Assistant Professor at Loyola College, Research Assistant at the Bioinformatics Infrastructure Facility (DBT, Madras Christian College), and educator at Our Lady’s Matriculation Higher Secondary School, handling subjects including molecular biology, clinical research management, bioinformatics, programming in C++, and biophysics. Her key contributions include docking studies of bioflavonoids targeting anti-apoptotic pathways, development of bioinformatics infrastructure, and designing interdisciplinary educational programs that integrate biotechnology and computational biology. She has been recognized with the T. A. Venkateswaran Prize (II Rank, M.Sc.) and a Gold Medal (I Rank, M.Phil.), alongside multiple institutional awards for research and academic excellence. Dr. R Sagaya Jansi actively participates in academic societies, departmental leadership and IQAC coordination, mentoring students and contributing to curriculum development. Her work advances scientific understanding, fosters innovation, and supports global knowledge dissemination. Author metrics: 7 documents, 70 citations, h-index 4. With strong potential for international collaborations, Q1 publications, and research leadership, Dr. R Sagaya Jansi is highly deserving of recognition for advancing bioinformatics and biotechnology research excellence.

Profile: Scopus | ORCID | ResearchGate | Scispace | Stella Maris College | LinkedIn

Featured Publications

1. Sagaya Jansi, R., Khusro, A., Agastian, P., Kumar, G. A., Kadaikunnan, S., Khaled, J. M., & Thiruvengadam, M. (2024). Bioassay-guided fractionation and in vitro and in silico biological activities of 2,4-di-tert-butylphenol isolated from Nocardiopsis sp. strain LC-8. Chinese Journal of Analytical Chemistry.

2. Latha, R., Sarkar, T., Sagaya, J. R., & Agastian, P. (2015). Evaluation of antimicrobial efficiency and alpha-glucosidase inhibition of Rubus ellipticus Smith. leaf extracts and its phytochemical analysis. Asian Journal of Pharmaceutical and Clinical Research, 8(2), 422–426.

3. Latha, R., Saravana Kumar, P., Sagaya Jansi, R., Venkatadri, B., & Agastian, P. (2015). Antimicrobial efficacy and α-glucosidase inhibition of Passiflora mollissima Bailey leaves and its phytochemical analysis. International Journal of Pharmaceutical Research and BioScience, 4(4), 62–78.

4. Aparna, K., Sagaya Jansi, R., Arul Samraj, D., & Joyce PriyaKumari, C. (2013). Homology modelling and docking studies of phospholipase A2 enzyme of Apis mellifera. Journal of Current Pharmaceutical Research, 11(1), 33–37.

5. Joyce Priyakumari, C., Aparna, K., Sagaya Jansi, R., & Gladies Kezia. (2014). Phytochemical analysis of Didymocarpus pedicellatus. International Journal of Pharmaceutical Sciences Review and Research, 25(1), 307–309.

 

Mozhgan Abasi | Biotechnology | Best Researcher Award

Published on by New Scientists

Assist. Prof. Dr. Mozhgan Abasi | Biotechnology | Best Researcher Award

Mozhgan Abasi at Mazandaran University of Medical Sciences, Iran.

Assist. Prof. Dr. Mozhgan Abasi is a Medical Biotechnology researcher with expertise in stem cell therapy, tissue engineering, genetic engineering, and bioinformatics. She earned her Ph.D. in Medical Biotechnology from Tabriz University of Medical Sciences, Iran, where she focused on lentiviral vector-mediated gene expression in apoptosis pathways. With a strong background in molecular and cellular biology, she has conducted extensive research in induced pluripotent stem cells (iPSCs), cancer stem cells, and non-coding RNA. Dr. Abasi is a member of multiple scientific societies, including the Iran Biotechnology Society and the iPS Biotechnology Team. Her work integrates molecular techniques, bioinformatics, and microbiological approaches to advance regenerative medicine and genetic research.

Publication Profile

Scopus

Orcid

Google Scholar

Educational Details

  • Ph.D. in Medical Biotechnology (2011-2017) – Tabriz University of Medical Sciences, Tabriz, Iran
    Thesis: Study on the effect of lentiviral vector-mediated 7SK snRNA overexpression on mRNA levels of apoptosis-related markers BCL2 and BAX in HEK293T cells.
  • M.Sc. in Molecular and Cellular Biology (2009-2011) – National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran
    Thesis: The study of dopaminergic differentiation of Nurr1 and GPX1 co-expressing ES cells induced by BBA.
  • B.Sc. in Biotechnology (2004-2008) – Department of Biology, Faculty of Science, Al Zahra University, Tehran, Iran.

Professional Experience

Dr. Mozhgan Abasi is an Assistant Professor specializing in Medical Biotechnology. She has extensive expertise in stem cell research, genetic engineering, bioinformatics, and cancer biology. Her research focuses on iPS (induced pluripotent stem) cell generation, stem cell differentiation, tissue engineering, and nanoporous biomaterials. With a strong foundation in molecular and cellular biology, she has contributed significantly to understanding stem cell therapy and regenerative medicine.

Dr. Abasi has been an active member of multiple professional societies, including the Iran Bioinformatics Society (IBS), Iran Genetic Society (IGS), Iran Biotechnology Society, and the iPS Biotechnology Team (IBT). She has extensive experience in molecular techniques such as gene expression analysis, cloning, viral and non-viral gene transfer, and protein analysis methods like Western blotting and immunocytochemistry. Additionally, she is proficient in a range of bioinformatics tools used for primer design, shRNA analysis, gene expression studies, and molecular dynamics simulations.

Research Interest

  • Stem Cell Therapy
  • Tissue Engineering
  • Induced Pluripotent Stem Cells (iPSCs)
  • Cancer Stem Cells
  • Immune System Research
  • Microarray Analysis
  • Nanoporous Biomaterials
  • Bioinformatics & Non-Coding RNA
  • Genetic Engineering

Author Metrics

  • Total Citations: 1,821+

  • h-index: 17

  • i10-index: 6+

Top Noted Publication

  • Carbon nanotubes: properties, synthesis, purification, and medical applications

    • Citations: 1,462

    • Journal: Nanoscale Research Letters

    • Year: 2014

  • The effect of topography on differentiation fates of matrigel-coated mouse embryonic stem cells cultured on PLGA nanofibrous scaffolds

    • Citations: 101

    • Journal: Tissue Engineering Part A

    • Year: 2012

  • Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer

    • Citations: 94

    • Journal: Journal of Microencapsulation

    • Year: 2014

  • Recent advances on nanomaterials-based fluorimetric approaches for microRNAs detection

    • Citations: 91

    • Journal: Materials Science and Engineering: C

    • Year: 2019

  • Anti-tumoral properties of Punica granatum (Pomegranate) peel extract on different human cancer cells

    • Citations: 73

    • Journal: Asian Pacific Journal of Cancer Prevention

    • Year: 2015

  • Anti-proliferative properties of Cornus mass fruit in different human cancer cells

    • Citations: Over 50

    • Journal: Asian Pacific Journal of Cancer Prevention

    • Year: Not specified

Conclusion

Assist. Prof. Dr. Mozhgan Abasi is an exceptional researcher with significant contributions to biotechnology, genetic engineering, and regenerative medicine. Her high citation impact, strong expertise in molecular biology, and interdisciplinary research focus make her a strong contender for the Best Researcher Award.

While her achievements are commendable, further expanding international collaborations, increasing high-impact publications, and securing major research grants would solidify her position as a leading global researcher. Overall, Dr. Abasi is highly deserving of recognition for her contributions to the scientific community and biotechnology advancements.